The actions of estrogens on the cardiovascular system occur either indirectly
through the modification of cardiovascular risk factors [reduction of plasma LDL
cholesterol, elevation of HDL cholesterol, effect on hemostatic factors (reduction of
fibrinogen and inhibitors of fibrinolysis)] or directly mediated by the estrogen receptors
(ERs, defined as genomic action of estrogens) or other receptors. In this chapter, the
overall actions of estrogens on the cardiovascular system and particularly on the
vascular wall, as well as actions of estrogens on many different metabolic pathways
affecting the cardiovascular system will be analyzed. The indirect actions of estrogen
on the circulatory and hematological system, body composition, lipids and glucose
metabolisms will be analyzed. There are several causes leading to the development of
early onset of coronary heart disease in young women. These causes can be classified
into five categories: 1) Vasculitis and autoimmune diseases, 2) Hypercoagulable states,
3) Non-atherosclerotic coronary heart disease, 4) Myocardial infarction in
hallucinogenic drug abusers, and 5) Atherosclerotic coronary heart disease. The causes
leading to an early onset of coronary heart disease in young women will be analyzed.
Keywords: Anti-inflammatory, Anti-proliferative, Autoimmune diseases,
Coronary heart disease, Diabetes mellitus, Dyslipidemia, Estrogens, Genomic,
Hypertension, Metabolic syndrome, Non-genomic, Vascular endothelium,
Vasculitis, Vasodilation.
